“How is Prostate Cancer Detected?” featuring Drs. Tewari and Schlegel (ProstateCancerMD)
Posted by admin on Sep 7, 2009 under Prostate Cancer Antigen
“PSA allows us to detect prostate cancer several years before that nodule would develop, at a much earlier stage, and therefore at a much more curable stage.” Drs. Schlegel (Department Chairman) and Tewari of Cornell Urology discuss the application of PSA tests, digital rectum exams, and other approaches that enable urologists to diagnose prostate cancer earlier. A family history of prostate cancer and the implications relative to a diagnosis of prostate cancer is also discussed. The need to receive a PDA and at what age is also covered by one of the leading prostate cancer researchers.
Duration : 0:1:25
“There’s no doubt that if the cancer is picked up early, it gives many more treatment options than if it’s picked up later.” Dr. Tewari (leader in prostate cancer research and surgery) of Cornell Urology discusses the critical importance of early detection in prostate cancer and the benefits it has for prostate cancer patients.
Prostate cancer survivor Mr. Ernest Barbuti & Dr. Donald Urban discuss the choice of radiation treatment for prostate cancer.
“The most important thing to prevent prostate cancer is to pick your parents properly.” Dr. Schlegel (Department Chairman) of Cornell Urology discusses a question they face often—Can prostate cancer be prevented? They discuss the role of race, diet, genetic profile and review important steps we can take to decrease our risk of facing prostate cancer.
“It’s like poking into a pillow in which a couple of golf balls are hidden.” Dr. Tewari, of the Dept. of Urology at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, discusses the prostate cancer biopsy and its effectiveness. While it’s the best they have, it is not perfect.
“The outcomes from surgical treatment of prostate cancer are dependent on the patient’s age, on the extent of the tumor, and to some degree the experience and results that an individual surgeon gets.” Dr. Schlegel, of the Dept. of Urology at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, explains common expectations for patients entering into prostate cancer surgery and what factors those expectations are founded upon.
“The key in watchful waiting is not waiting, it’s watchful intervention.” Dr. Tewari, of the Dept. of Urology at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, discusses the fact that surgery and immediate treatment for prostate cancer patients is not the optimal choice for certain prostate cancer patients.
“Radiation therapy is an effective way to suppress or destroy prostate cancer.” Dr. Schlegel (Department Chairman) of Cornell Urology discusses the process a patient enters when evaluating the risks of various treatments for prostate cancer including an acceptance of the risks and a balancing of the benefits. In this prostate cancer health video, the focus is on radiation therapy. This approach may allow patients to avoid major prostate cancer operation, but it is not without risk.
Gerald Aptaker, 71. Stage IV Prostate Cancer with multiple bone metastases in bilateral ribs, thoracic spine, sacrum, pelvis and left femur responded dramatically to the Issels Treatment. Within 3 weeks the PSA of 3,524 dropped to 639.9, pain minimized, appetite and overall well being improved and energy level went up. Laboratory studies of July 1st, about 1 month after Geralds discharge from the Issels Treatment Center, showed a PSA level of 17.27 and Gerald reported a substantial improvement in his quality of life, with practically no bone pain, no limitations in his range of motion. August 7th, 2008: His PSA dropped to 2.00. Gerald is very optimistic and eager to continue his complete home treatment protocol. On January 21, 2009 the PSA was 1.07 and Gerald is very happy. On April 4, 2009 Gerald reports that his PSA dropped to 0.56 and he feels excellent.